Wednesday, 20 March 2019

Jazz Pharma's sleep disorder treatment gets FDA nod

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)